Future studies must elucidate whether the opening of hemichannels and pannexons in the CNS could contribute to inflammation and the redox imbalance observed in MS by a mechanism involving the dysfunction of Nrf2 signaling. The gene discussed is NFE2L2; the disease is myeloid sarcoma.